Lu Hongbo 4
4 · Zenas BioPharma, Inc. · Filed Sep 16, 2024
Insider Transaction Report
Form 4
Lu Hongbo
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-12+37,000→ 37,000 totalExercise: $17.00Exp: 2034-09-11→ Common Stock (37,000 underlying)
Footnotes (1)
- [F1]The option vests in equal annual installments over three years beginning on September 12, 2025, the first anniversary of the vesting commencement date, subject to continued service.